Cancer
Quiénes somos
DETERMINE Trial Treatment Arm 2: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
Estudio de BMS-986253 en combinación con nivolumab o nivolumab más ipilimumab en cánceres avanzados.
Protocolo de redescubrimiento de fármacos (ensayo DRUP)
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Adoptive Cell Therapy Across Cancer Diagnoses
